Literature DB >> 11564422

Impact of antipsychotic drug administration on the expression of nuclear receptors in the neocortex and striatum of the rat brain.

M C Langlois1, G Beaudry, H Zekki, C Rouillard, D Lévesque.   

Abstract

We have recently shown that the expression of the nerve growth factor-inducible gene B (NGFI-B, or Nur77), a transcription factor belonging to the large ligand-activated nuclear receptor family, is modulated by antipsychotic drugs in the rat forebrain. In the present work, we have investigated the impact of antipsychotic drugs on a series of transcription factors also belonging to the nuclear receptor family. The receptors investigated include retinoid X receptor (RXR), thyroid hormone receptor (TR), retinoic acid receptor (RAR), RAR-related orphan receptor (RZR) and Rev-erb receptor isoforms in addition to the NGFI-B transcript. We have used in situ hybridization to monitor their mRNA levels after acute and chronic antipsychotic drug administration. RZRbeta and NGFI-B mRNA levels are down-regulated after chronic haloperidol or clozapine treatment in the primary somatosensory cortex. The TRbeta1 isoform mainly expressed in the cingulate cortex is modulated only after chronic clozapine treatment, whereas TRalpha isoform mRNAs are modulated by both antipsychotics in the cingulate cortex and nucleus accumbens shell; two brain areas associated with limbic functions. The RXRgamma1 isoform, mostly expressed in the dorsolateral portion of the striatum is modestly affected by antipsychotics. Modulation of the expression of transcription factors belonging to the ligand-activated nuclear receptor family by antipsychotics represents an additional molecular event in the mechanism of action of these drugs. We suggest that modification of the pattern of transcription factor expression may play a role in long-term cellular responses to these drugs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564422     DOI: 10.1016/s0306-4522(01)00248-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  16 in total

Review 1.  Nur77 and retinoid X receptors: crucial factors in dopamine-related neuroadaptation.

Authors:  Daniel Lévesque; Claude Rouillard
Journal:  Trends Neurosci       Date:  2006-11-28       Impact factor: 13.837

2.  Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid.

Authors:  Souha Mahmoudi; Pershia Samadi; François Gilbert; Bazoumana Ouattara; Marc Morissette; Laurent Grégoire; Claude Rouillard; Thérèse Di Paolo; Daniel Lévesque
Journal:  Neurobiol Dis       Date:  2009-07-25       Impact factor: 5.996

Review 3.  The role of NR4A transcription factors in memory formation.

Authors:  Josh D Hawk; Ted Abel
Journal:  Brain Res Bull       Date:  2011-02-18       Impact factor: 4.077

4.  Medical Co-morbidities Among Patients with Severe Mental Illnesses in a Community Health Facility in Nigeria.

Authors:  Victor Olufolahan Lasebikan; Joachim Azegbeobor
Journal:  Community Ment Health J       Date:  2016-11-25

5.  Modulation of haloperidol-induced patterns of the transcription factor Nur77 and Nor-1 expression by serotonergic and adrenergic drugs in the mouse brain.

Authors:  Jérôme Maheux; Laura Vuillier; Mylène Mahfouz; Claude Rouillard; Daniel Lévesque
Journal:  Int J Neuropsychopharmacol       Date:  2011-04-28       Impact factor: 5.176

6.  The transcription factors Nur77 and retinoid X receptors participate in amphetamine-induced locomotor activities.

Authors:  Emmanuelle Bourhis; Jérôme Maheux; Brigitte Paquet; Hiroyuki Kagechika; Koichi Shudo; Pierre-Paul Rompré; Claude Rouillard; Daniel Lévesque
Journal:  Psychopharmacology (Berl)       Date:  2008-10-09       Impact factor: 4.530

7.  Haloperidol-induced striatal Nur77 expression in a non-human primate model of tardive dyskinesia.

Authors:  Souha Mahmoudi; Pierre J Blanchet; Daniel Lévesque
Journal:  Eur J Neurosci       Date:  2013-03-31       Impact factor: 3.386

Review 8.  Relevance of animal models to human tardive dyskinesia.

Authors:  Pierre J Blanchet; Marie-Thérèse Parent; Pierre H Rompré; Daniel Lévesque
Journal:  Behav Brain Funct       Date:  2012-03-09       Impact factor: 3.759

9.  Thyroid dysfunction in major psychiatric disorders in a hospital based sample.

Authors:  Rajiv Radhakrishnan; Sam Calvin; Jyotin Kshitiz Singh; Binston Thomas; Krishnamachari Srinivasan
Journal:  Indian J Med Res       Date:  2013-12       Impact factor: 2.375

10.  Long-term therapeutic drug monitoring of risperidone and olanzapine identifies altered steady-state pharmacokinetics: a clinical, two-group, naturalistic study.

Authors:  John K Darby; David J Pasta; Michael G Wilson; John Herbert
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.